NeoX Biotech
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $40M
Investors
- 8
About NeoX Biotech
Established in 2018 and based in Beijing, China, NeoX Biotech is a enterprise in the field of biopharmaceuticals. The company was founded by Dr.D. in physical chemistry from MIT and has a strong background in computational immunology. Dr. Chen's expertise is complemented by a multidisciplinary team with expertise in computational chemistry, biophysics, AI, immunology, oncology, and medicinal chemistry. The team includes researchers from prestigious institutions such as Peking University, the Max Planck Institute for Infection Biology, and Merck & Co. NeoX Biotech has established strategic partnerships with global biomedical companies to accelerate drug R&D pipelines and has received recognition through awards such as the first place in the LEO Pharma Innovation Competition. specializes in the research and development of macromolecular and multispecific drugs, particularly in the area of immuno-oncology. The company's neoPlatform technology integrates AI, computational biophysics, and high-throughput experimental data to drive the discovery of therapeutics, focusing on protein-protein interactions (PPIs). This approach has been applied to various innovative drug modalities, including nanobodies, fusion proteins, bispecific antibodies, and protein degraders, aiming to develop "First-in-Class" or "Best-in-Class" drug products. The company generates revenue through the development and potential commercialization of its innovative drug pipeline, including partnerships and collaborations with pharmaceutical companies for drug discovery and development.
Who invested in NeoX Biotech
8 investors across 3 rounds
See all investors in NeoX Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeoX Biotech
Who invested in NeoX Biotech?
NeoX Biotech has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeoX Biotech raised?
NeoX Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NeoX Biotech last raise money?
NeoX Biotech's most recent round on record is a Series A, in Jul 2021.
What does NeoX Biotech do?
Established in 2018 and based in Beijing, China, NeoX Biotech is a enterprise in the field of biopharmaceuticals.
Where is NeoX Biotech headquartered?
NeoX Biotech is headquartered in Beijing, China.
Which VCs invest in companies like NeoX Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NeoX Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NeoX Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.